Langcongan, Aisa .
HRN: 09-47-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/06/2024
08/13/2024
IVT
600 Mg
Q6H
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes